Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-10-26

Clinical Trial Update: Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC)

View source ↗

Summary

A retrospective observational study on fluciclovine (18F) FACBC in prostate cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • fluciclovine (18F) FACBC (fluciclovine)

Snippet

Sponsor: Blue Earth Diagnostics | Conditions: Prostatic Neoplasms | Status: COMPLETED | Results posted: 2018-10-26